John William Wulf - 02 Jun 2026 Form 4 Insider Report for agilon health, inc. (AGL)

Reporting relationship: Director
Issuer ticker: AGL
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 21:57:15 UTC
Prior SEC filing: 30 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Mimi Yang, as Attorney-in-Fact

Key filing fact

John William Wulf filed Form 4 for agilon health, inc. (AGL) on 04 Jun 2026.

Key facts

This page summarizes John William Wulf's Form 4 filing for agilon health, inc. (AGL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2026, 21:57.

Change

Previous filing in this sequence was filed on 30 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856345 Primary reporting owner

Wulf John William

Relationship: Director
Address: C/O AGILON HEALTH, INC., 440 POLARIS PARKWAY, SUITE 550, WESTERVILLE
Signature: /s/ Mimi Yang, as Attorney-in-Fact
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGL transaction

Common Stock

Award

Transaction value
Shares: +2,133
Change %: +15%
Price: $0.000000^*
Shares after: 16,765
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director

Footnote F2

The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

Footnote F3

Includes restricted stock units.